Sur8 mediates tumorigenesis and metastasis in colorectal cancer.
- Author:
Young Mi LEE
1
;
Saluja KADUWAL
;
Kug Hwa LEE
;
Jong Chan PARK
;
Woo Jeong JEONG
;
Kang Yell CHOI
Author Information
- Publication Type:Original Article
- MeSH: Animals; Carcinogenesis*; Cell Line; Colorectal Neoplasms*; Doxycycline; HCT116 Cells; Humans; Liver; Mice; Mice, Nude; Neoplasm Metastasis*; Phosphotransferases
- From:Experimental & Molecular Medicine 2016;48(7):e249-
- CountryRepublic of Korea
- Language:English
- Abstract: Sur8, a scaffold protein of the Ras pathway, interacts with Ras and Raf and modulates the Ras-extracellular signal-regulated kinase (ERK) pathway. Here we show that Sur8 is overexpressed in established human colorectal cancer (CRC) cell lines and CRC patient tissues. Moreover, Sur8 expression is increased during liver metastasis in CRC patients. Sur8 knockdown decreases ERK and Akt activities in CRC cell lines, regardless of their K-Ras, B-Raf or PI3K mutation status. Overexpression or knockdown of Sur8 increases or decreases, respectively, the proliferation or transformation of CRC cell lines. Sur8 knockdown attenuates the migration and invasion of HCT116 CRC cells. Subcutaneous or orthotopic injection of HCT116 cells harboring a doxycycline (Dox)-mediated Sur8 knockdown system in nude mice resulted in decreased tumorigenic potential and inhibited the liver metastatic potential of HCT116 cells. Taken together, our data support the role of Sur8 as a promoter of tumorigenesis and liver metastasis in CRC through its modulation of the Ras-ERK and PI3K-Akt signaling pathways.
